ORTEXORTEX News
Tracking MTZ? Get live short interest, options flow, and signals on ORTEX.Sign up free →
MT
Earnings PreviewMTZ

MasTec Rebounds, But Analysts Have Already Cut Deep

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 2 Nov 2026, 04:01

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

MasTec is an infrastructure contractor specializing in energy, communications, and pipeline work. It reports Q3 results on November 5, three trading days after closing at $186.06, up 8.8% on the week, broadly in line with the 7.2% median gain across its closest peers.

The stock's recovery follows a brutal October. Shares fell 11.5% over the past month before this week's bounce. The peer group moved with it: PWR gained 13.6% on the week and MYRG added 11.1%, suggesting the sector-wide selloff rather than company-specific news drove the damage, and the rebound has a similar character. The borrow market confirms there is no active short campaign behind the weakness. Availability is running at 2,454%, meaning more than 24 shares are available to lend for every one currently borrowed. Cost to borrow is 0.45%, unchanged in character from the readings reported in earlier ORTEX coverage. Short interest has fallen 13.8% over the past month to 5.8% of the free float. The lending market is as relaxed as it was before the earnings event on October 29.

The real story heading into this print is the gap between where the stock trades and where analysts think it should. The consensus mean target is $353.76, nearly double the current price. Yet that gap reflects a wave of cuts, not conviction. Every major firm that touched the stock in October lowered its target: Citigroup cut from $408 to $308, JP Morgan from $369 to $303, Barclays from $340 to $320, and TD Cowen from $420 to $320. All maintained positive ratings. The Street is not abandoning MasTec, but it is repricing the near-term outlook sharply downward. The factor score for analyst recommendation differential ranks in the 93rd percentile, which reflects how uniformly bullish the formal ratings remain, even as the targets compress. Bears point to the specifics: Communications revenue guidance was cut sharply, 4Q EBITDA was guided roughly 5% below consensus after the last print, and forward estimates have been trimmed 7% to 10%. The bull case rests on a backlog of roughly $21 billion, a book-to-bill above 1.2x, and the Superior acquisition adding electrical capability for data-centre work.

Ownership adds an unusual dimension. Jorge Mas and Jose Ramon Mas, the company's controlling family, both hold Schedule 13D filings, meaning they are on the SEC's activist register. Jorge Mas holds 14.8% of shares, down from 15.0% at the prior filing in August. Jose Ramon Mas holds 7.7%. The 13D designation reflects the founding family's retained control rather than an outside agitator, but the position is large and any change in family stance would be material. Separately, BlackRock added 584,000 shares in the most recently reported quarter, while JP Morgan Asset Management added over 1.1 million, a notable increase relative to its prior position. Insider activity from directors in August was confined to routine compensation grants and small tax withholdings, none of which carry directional signal.

The November 5 print will test whether the backlog MasTec is citing translates into the near-term margin and revenue trajectory that the current price implies, or whether the analyst target cuts of October were the first step in a longer reassessment.

Stocks in this article

See the live data behind this article on ORTEX.

Open MTZ on ORTEX →

How this article was generated

Generated
2 Nov 2026, 04:12
Data as of
2 Nov 2026, 04:01
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.